<?xml version='1.0' encoding='utf-8'?>
<document id="29550740"><sentence text="Factors associated with concurrent heroin use among patients on methadone maintenance treatment in Vietnam: A 24-month retrospective analysis of a nationally representative sample."><entity charOffset="64-73" id="DDI-PubMed.29550740.s1.e0" text="methadone" /></sentence><sentence text="Methadone maintenance treatment (MMT) is highly effective for reducing heroin use and HIV transmission among people who inject opioids"><entity charOffset="0-9" id="DDI-PubMed.29550740.s2.e0" text="Methadone" /></sentence><sentence text=" We sought to measure and understand factors associated with continued heroin use, a critical factor affecting treatment outcome among MMT patients in Vietnam" /><sentence text="" /><sentence text="We collected data from medical charts of a nationally representative sample of patients who were on MMT from May 2008 to December 2013" /><sentence text=" We selected 10 MMT clinics using probability proportional to size and 50 patients/clinic by systematic random sampling" /><sentence text=" Concurrent heroin use was defined by self-report/positive urine test recorded in patient charts during month 3, 6, 12, and 24 after MMT initiation" /><sentence text=" We used multivariable logistic regression to identify factors associated with concurrent heroin use over the first 24 months in treatment" /><sentence text="" /><sentence text="All clients used heroin at baseline; concurrent heroin use was 55% at month 3; 19%, 14" /><sentence text="6% and 15" /><sentence text="2% at month 6, 12, and 24, respectively" /><sentence text=" Having no family emotional/financial support at baseline versus having this support (AOR = 2" /><sentence text="03; 95% confidence interval [CI] = 1" /><sentence text="17-3" /><sentence text="53); using heroin for &lt;15 years versus ≥15 years at baseline (AOR = 1" /><sentence text="55; 95% CI = 1" /><sentence text="01-2" /><sentence text="38); being HIV-infected/not on antiretroviral treatment (ART; AOR = 1" /><sentence text="79; 95% CI = 1" /><sentence text="07-2" /><sentence text="98) or being HIV infected/on ART (AOR = 2" /><sentence text="39; 95% CI = 1" /><sentence text="61-3" /><sentence text="55), versus not being HIV infected; baseline methamphetamine use versus non-use (AOR = 2"><entity charOffset="45-60" id="DDI-PubMed.29550740.s25.e0" text="methamphetamine" /></sentence><sentence text="68; 95% CI = 1" /><sentence text="08-6" /><sentence text="65), were associated with increased odds of concurrent heroin use among patients" /><sentence text="" /><sentence text="The association between concurrent heroin use among MMT patients and lack of family emotional/financial support, highlights the critical importance of these types of support for successful treatment" /><sentence text=" Association with shorter heroin use history suggests motivational enhancement may reduce concurrent heroin use" /><sentence text=" Living with HIV, whether on ART or not, is associated with increased concurrent heroin use and suggests safe injection commodities and education, and drug-drug interaction management, are needed for this subgroup" /><sentence text=" Though few MMT clients reported baseline methamphetamine use, its association with later heroin use suggests the need for effective methamphetamine use interventions"><entity charOffset="42-57" id="DDI-PubMed.29550740.s33.e0" text="methamphetamine" /><entity charOffset="133-148" id="DDI-PubMed.29550740.s33.e1" text="methamphetamine" /><pair ddi="false" e1="DDI-PubMed.29550740.s33.e0" e2="DDI-PubMed.29550740.s33.e0" /><pair ddi="false" e1="DDI-PubMed.29550740.s33.e0" e2="DDI-PubMed.29550740.s33.e1" /></sentence><sentence text="" /></document>